Multi ‑omics approach to improve patient‑tailored therapy using immune checkpoint blockade and cytokine‑induced killer cell infusion in an elderly patient with lung cancer: A case report and literature review

In conclusion, multi-omics analysis may be used to establish patient-tailored therapies to improve clinical outcomes in hard-to-treat elderly patients with metastatic NSCLC.PMID:38516684 | PMC:PMC10955685 | DOI:10.3892/ol.2024.14334
Source: Oncology Letters - Category: Cancer & Oncology Authors: Source Type: research